|
| 绝经后妇女骨质疏松症的管理：北美绝经协会2021年立场声明解读 |
| Management of osteoporosis in postmenopausal women: Interpretation of the 2021 position statement of the North American menopausal Association |
| |
| DOI：10.3969/j.issn.1006-7108.2022.08.027 |
| 中文关键词: 双膦酸盐 骨密度 钙 雌激素激动剂/拮抗剂 跌倒 骨折 骨质疏松症 甲状旁腺激素受体激动剂 绝经后 预防 RANK配体抑制剂 维生素 D |
| 英文关键词:bisphosphonates bone mineral density calcium estrogen agonists/antagonists falls fractures osteoporosis parathyroid hormone-receptor agonists post-menopause prevention RANK ligand inhibitors Vitamin D |
| 基金项目:基金项目：河北省卫生健康委医学试用项目：骨转换标志物在2型糖尿病合并骨质疏松患者骨折风险预测中的应用(GZ2020068) |
|
| 摘要点击次数: 841 |
| 全文下载次数: 0 |
| 中文摘要: |
| 摘要：骨质疏松症在老年绝经后妇女中普遍存在，骨质疏松会增加骨折的风险，与较高的发病率和死亡率有关。最近，北美绝经协会(North American Menopause Society，NAMS)招募了代谢性骨病和(或)女性健康领域的临床专家小组，回顾过去10年中有关骨质疏松症的筛查、预防、诊断和管理的证据，根据新证据和临床判断回顾并更新了NAMS 2010年发表的关于绝经后妇女骨质疏松症管理的立场声明。笔者对该指南的主要内容进行解读。 |
| 英文摘要: |
| Abstract: Osteoporosis, especially prevalent in older postmenopausal women, increases the risk of fractures that can be associated with significant morbidity and mortality. Recently, NAMS enlists a panel of clinical experts in the field of metabolic bone disease and/or women's health to review the evidence on screening, prevention, diagnosis, and management of osteoporosis over the past decade, reviews and updates The North American Menopause Society (NAMS) position statement on the management of osteoporosis in postmenopausal women published in 2010 in light of new evidence and clinical judgment. This article provides an interpretation of the main content of the guideline. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |